Literature DB >> 16611417

Melanocyte transformation associated with substrate adhesion impediment.

Sueli M Oba-Shinjo1, Mariangela Correa, Tatiana I Ricca, Fernanda Molognoni, Maria A Pinhal, Izabel A Neves, Sueli K Marie, Lúcia O Sampaio, Helena B Nader, Roger Chammas, Miriam G Jasiulionis.   

Abstract

Exclude experimental models of malignant transformation employ chemical and physical carcinogens or genetic manipulations to study tumor progression. In this work, different melanoma cell lines were established after submitting a nontumorigenic melanocyte lineage (melan-a) to sequential cycles of forced anchorage impediment. The great majority of these cells underwent anoikis when maintained in suspension. After one deadhesion cycle, phenotypic alterations were noticeable in the few surviving cells, which became more numerous and showed progressive alterations after each adhesion impediment step. No significant differences in cell surface expression of integrins were detected, but a clear electrophoretic migration shift, compatible with an altered glycosylation pattern, was observed for beta1 chain in transformed cell lines. In parallel, a progressive enrichment of tri- and tetra-antennary N-glycans was apparent, suggesting increased N-acetylglucosaminyltransferase V activity. Alterations both in proteoglycan glycosylation pattern and core protein expression were detected during the transformation process. In conclusion, this model corroborates the role of adhesion state as a promoting agent in transformation process and demonstrates that cell adhesion disturbances may act as carcinogenic stimuli, at least for a nontumorigenic immortalized melanocyte lineage. These findings have intriguing implications for in vivo carcinogenesis, suggesting that anchorage independence may precede, and contribute to, neoplastic conversion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611417      PMCID: PMC1578519          DOI: 10.1593/neo.05781

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  52 in total

Review 1.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.

Authors:  Dongfang Liu; Zachary Shriver; Ganesh Venkataraman; Yosuf El Shabrawi; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis.

Authors:  M D Hulett; C Freeman; B J Hamdorf; R T Baker; M J Harris; C R Parish
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

4.  alpha6beta1-Integrin, a major cell surface carrier of beta1-6-branched oligosaccharides, mediates migration of EJ-ras-transformed fibroblasts on laminin-1 independently of its glycosylation state.

Authors:  M G Jasiulionis; R Chammas; A M Ventura; L R Travassos; R R Brentani
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

5.  N-acetylglucosaminyltransferase V modifies the signaling pathway of epidermal growth factor receptor.

Authors:  P Guo; Q Y Wang; H B Guo; Z H Shen; H L Chen
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

Review 6.  Dynamics of cell interactions and communications during melanoma development.

Authors:  G Li; K Satyamoorthy; M Herlyn
Journal:  Crit Rev Oral Biol Med       Date:  2002

Review 7.  Remodeling of the microenvironment by aggressive melanoma tumor cells.

Authors:  Mary J C Hendrix; Elisabeth A Seftor; Dawn A Kirschmann; Vito Quaranta; Richard E B Seftor
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

Review 8.  Issues in the epidemiology of melanoma.

Authors:  S Oliveria; S Dusza; M Berwick
Journal:  Expert Rev Anticancer Ther       Date:  2001-10       Impact factor: 4.512

Review 9.  Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer.

Authors:  József Tímár; Károly Lapis; József Dudás; Anna Sebestyén; László Kopper; Ilona Kovalszky
Journal:  Semin Cancer Biol       Date:  2002-06       Impact factor: 15.707

10.  Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells.

Authors:  H B Nader; V Buonassisi; P Colburn; C P Dietrich
Journal:  J Cell Physiol       Date:  1989-08       Impact factor: 6.384

View more
  31 in total

1.  Epigenetic reprogramming as a key contributor to melanocyte malignant transformation.

Authors:  Fernanda Molognoni; Adriana T Cruz; Fabiana M Meliso; Alice S Morais; Camila F Souza; Patrícia Xander; Jared M Bischof; Fabrício F Costa; Marcelo B Soares; Gangning Liang; Peter A Jones; Miriam G Jasiulionis
Journal:  Epigenetics       Date:  2011-04-01       Impact factor: 4.528

2.  L1CAM from human melanoma carries a novel type of N-glycan with Galβ1-4Galβ1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells.

Authors:  Dorota Hoja-Łukowicz; Paweł Link-Lenczowski; Andrea Carpentieri; Angela Amoresano; Ewa Pocheć; Konstantin A Artemenko; Jonas Bergquist; Anna Lityńska
Journal:  Glycoconj J       Date:  2012-04-29       Impact factor: 2.916

3.  Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation.

Authors:  Tatiana I Ricca; Gangning Liang; Ana Paula M Suenaga; Sang W Han; Peter A Jones; Miriam G Jasiulionis
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

4.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

5.  Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanoma.

Authors:  Amanda Gonçalves Dos Santos Silva; Herbert Alexander Graves; Amanda Guffei; Tatiana Iervolino Ricca; Renato Arruda Mortara; Miriam Galvonas Jasiulionis; Sabine Mai
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715

6.  Metastatic melanoma positively influences pregnancy outcome in a mouse model: could a deadly tumor support embryo life?

Authors:  Rubens H Bollos; Mary U Nakamura; Valderez B V Lapchick; Estela M A F Bevilacqua; Mariangela Correa; Silvia Daher; Márcia M S Ishigai; Miriam G Jasiulionis
Journal:  Clin Exp Metastasis       Date:  2007-10-12       Impact factor: 5.150

7.  Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation.

Authors:  Ana C E Campos; Fernanda Molognoni; Fabiana H M Melo; Luciano C Galdieri; Célia R W Carneiro; Vânia D'Almeida; Mariangela Correa; Miriam G Jasiulionis
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

8.  miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients.

Authors:  Adriana Taveira da Cruz; Aline Hunger; Fabiana Henriques Machado de Melo; Ana Carolina Monteiro; Geneviève Catherine Paré; Dulce Lai; Débora Kristina Alves-Fernandes; Ana Luisa Pedroso Ayub; Esteban Mauricio Cordero; José Franco da Silveira Filho; Regine Schneider-Stock; Bryan Eric Strauss; Victor Tron; Miriam Galvonas Jasiulionis
Journal:  Neoplasia       Date:  2021-07-08       Impact factor: 5.715

9.  Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.

Authors:  Camila Ferreira de Souza; Patrícia Xander; Ana Carolina Monteiro; Amanda Gonçalves dos Santos Silva; Débora Castanheira Pereira da Silva; Sabine Mai; Viviane Bernardo; José Daniel Lopes; Miriam Galvonas Jasiulionis
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

10.  Activation of the kinin B1 receptor attenuates melanoma tumor growth and metastasis.

Authors:  Patricia Dillenburg-Pilla; Andrea G Maria; Rosana I Reis; Elaine Medeiros Floriano; Cacilda Dias Pereira; Fernando Luiz De Lucca; Simone Gusmão Ramos; João B Pesquero; Miriam G Jasiulionis; Claudio M Costa-Neto
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.